Part I All references in this report to Reviva, the Company, we, us, or our mean Reviva Pharmaceuticals Holdings, Inc. and its subsidiaries unless we state otherwise, or the context otherwise indicates. Business Combination and Domestication On December 14, 2020, our predecessor company, formerly known as Tenzing Acquisition Corp., a British Virgin Islands exempted company (Tenzing), and Reviva Pharmaceuticals, Inc., a Delaware corporation (together with its consolidated subsidiaries, Old Reviva...
Q2 FY2026 — expected 2026-09-19
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-30 | 2025-12-31 | 0001437749-26-010126 | EDGAR | 93K words |
| 2025-04-03 | 2024-12-31 | 0001437749-25-010791 | EDGAR | — |
| 2024-04-15 | 2023-12-31 | 0001437749-24-011955 | EDGAR | — |
| 2023-03-30 | 2022-12-31 | 0001437749-23-008502 | EDGAR | — |
| 2022-03-15 | 2021-12-31 | 0001437749-22-006332 | EDGAR | — |
| 2021-03-22 | 2020-12-31 | 0001437749-21-006681 | EDGAR | — |
| 2020-05-04 | 2020-02-29 | 0001104659-20-055760 | EDGAR | — |
| 2019-05-22 | 2019-02-28 | 0001144204-19-027771 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-13 | 2025-09-30 | 0001437749-25-034827 | EDGAR | 27K words |
| 2025-08-14 | 2025-06-30 | 0001437749-25-026967 | EDGAR | — |
| 2025-05-15 | 2025-03-31 | 0001437749-25-017191 | EDGAR | — |
| 2024-11-14 | 2024-09-30 | 0001437749-24-035375 | EDGAR | — |
| 2024-08-14 | 2024-06-30 | 0001437749-24-026571 | EDGAR | — |
| 2024-05-14 | 2024-03-31 | 0001437749-24-016366 | EDGAR | — |
| 2023-11-14 | 2023-09-30 | 0001437749-23-031973 | EDGAR | — |
| 2023-08-14 | 2023-06-30 | 0001437749-23-023686 | EDGAR | — |
| 2023-05-15 | 2023-03-31 | 0001437749-23-014582 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0001437749-22-027265 | EDGAR | — |
| 2022-08-15 | 2022-06-30 | 0001437749-22-020538 | EDGAR | — |
| 2022-05-16 | 2022-03-31 | 0001437749-22-012629 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-30 | 0001437749-26-010140 | EDGAR | 3K words |
| 2026-03-19 | 0001437749-26-009063 | EDGAR | — |
| 2026-03-05 | 0001437749-26-006991 | EDGAR | — |
| 2026-01-23 | 0001437749-26-001913 | EDGAR | — |
| 2025-12-23 | 0001437749-25-038602 | EDGAR | — |
| 2025-11-13 | 0001437749-25-034846 | EDGAR | — |
| 2025-10-17 | 0001437749-25-031278 | EDGAR | — |
| 2025-09-26 | 0001437749-25-029951 | EDGAR | — |
| 2025-09-19 | 0001437749-25-029531 | EDGAR | — |
| 2025-08-14 | 0001437749-25-026971 | EDGAR | — |
159 total filings indexed. 129 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001742927 |
| Ticker | RVPH |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.revivapharma.com |
| Listed | 2020-12-15 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report